'Palliative-D' Vitamin D to Palliative Cancer Patients
Status:
Completed
Trial end date:
2020-06-09
Target enrollment:
Participant gender:
Summary
To test the hypothesis that vitamin D treatment during 12 weeks to palliative cancer patients
can decrease opioid consumption, fatigue and infectious burden and increase quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
Region Stockholm Stockholm County Council, Sweden
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins